Rampurna Prasad Gullapalli has been named vice president of Drug Delivery Technologies at Pharmaceutics International Inc. (Pii). Dr. Gullapalli is responsible for providing strategic scientific and technical leadership in areas of softgel, liquid-filled hard capsules, and novel drug delivery technologies for Pii's contract development and manufacturing business.
"Prasad's extensive background in oral dosage form development adds to Pii's leadership position as a foremost provider of oral dosage form development and GMP manufacturing services to the pharmaceutical industry," said Steve King, senior vice president of Pii. "We look forward to him helping us continually grow our oral formulation development capabilities."
Prior to joining Pii, Dr. Gullapalli served as an associate director of Elan Pharmaceuticals, where he was responsible for preformulation and oral dosage form development. He also served in various scientific positions with increasing responsibilities at Chiron, Purdue Pharma, Banner Pharmacaps and R.P. Scherer (now Catalent).